Mecillinam - Reversion of Resistance and How to Test It.
作者信息
Frimodt-Moller Niels
机构信息
Dept. of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
出版信息
EBioMedicine. 2017 Sep;23:4-5. doi: 10.1016/j.ebiom.2017.08.023. Epub 2017 Aug 26.
Abstract
摘要
相似文献
1
Mecillinam - Reversion of Resistance and How to Test It.美西林——耐药性的逆转及其检测方法
EBioMedicine. 2017 Sep;23:4-5. doi: 10.1016/j.ebiom.2017.08.023. Epub 2017 Aug 26.
2
A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.美西林与阿莫西林/克拉维酸联合使用可恢复高产 TEM-1 型大肠埃希菌对美西林的敏感性。
J Antimicrob Chemother. 2017 Jul 1;72(7):1911-1914. doi: 10.1093/jac/dkx087.
3
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.美西林对耐第三代头孢菌素的大肠埃希菌的活性。
J Antimicrob Chemother. 2010 Jan;65(1):79-81. doi: 10.1093/jac/dkp404.
4
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.美西林与其他β-内酰胺类抗生素对产不同β-内酰胺酶大肠杆菌菌株的相对效价。
J Antimicrob Chemother. 2000 Sep;46 Suppl 1:9-14; discussion 63-5.
5
Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.美西林对产AmpCβ-内酰胺酶大肠杆菌的活性。
J Antimicrob Chemother. 2006 Jul;58(1):223-4. doi: 10.1093/jac/dkl198. Epub 2006 May 12.
6
7
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.美西林/克拉维酸联合制剂：产超广谱β-内酰胺酶大肠埃希菌引起的社区获得性单纯性尿路感染的一种可能选择。
J Antimicrob Chemother. 2012 Oct;67(10):2424-8. doi: 10.1093/jac/dks215. Epub 2012 Jun 4.
8
Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.临床分离株及实验室筛选的大肠杆菌突变体中氨比西林（美西林）耐药性突变
Antimicrob Agents Chemother. 2015 Mar;59(3):1718-27. doi: 10.1128/AAC.04819-14. Epub 2015 Jan 12.
9
In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.从孕妇尿液中分离出的大肠杆菌菌株对美西林的体外敏感性。
Med Mal Infect. 2016 Dec;46(8):436-441. doi: 10.1016/j.medmal.2016.07.007. Epub 2016 Sep 5.
10
Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.采用美国国家临床实验室标准化委员会（NCCLS）方法对大肠埃希菌尿液分离株进行美西林敏感性试验。
Int J Antimicrob Agents. 2005 Mar;25(3):198-204. doi: 10.1016/j.ijantimicag.2004.08.014. Epub 2005 Jan 5.
引用本文的文献
1
Antibiotic resistance in the invasive bacteria Escherichia coli.侵袭性大肠埃希菌的抗生素耐药性。
Cent Eur J Public Health. 2022 Jun;30(Supplement):S75-S80. doi: 10.21101/cejph.a7384.
本文引用的文献
1
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.大肠埃希菌在尿液中生长时高水平美西林耐药性向敏感性的恢复。
EBioMedicine. 2017 Sep;23:111-118. doi: 10.1016/j.ebiom.2017.08.021. Epub 2017 Aug 24.
2
Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.临床分离株及实验室筛选的大肠杆菌突变体中氨比西林（美西林）耐药性突变
Antimicrob Agents Chemother. 2015 Mar;59(3):1718-27. doi: 10.1128/AAC.04819-14. Epub 2015 Jan 12.
3
Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.匹美西林对产超广谱β-内酰胺酶大肠埃希菌或肺炎克雷伯菌所致尿路感染的临床及细菌学疗效
J Antimicrob Chemother. 2014 Mar;69(3):769-72. doi: 10.1093/jac/dkt404. Epub 2013 Oct 9.
4
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.与安慰剂治疗女性单纯性下尿路感染相比，不同剂量和疗程的匹美西林的临床及细菌学转归：下尿路感染女性项目（LUTIW项目）
Scand J Prim Health Care. 2007 Mar;25(1):49-57. doi: 10.1080/02813430601183074.
5
Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.匹美西林与氨苄西林治疗急性志贺菌病的疗效比较
Antimicrob Agents Chemother. 1984 May;25(5):643-5. doi: 10.1128/AAC.25.5.643.
6
6 -amidinopenicillanic acids--a new group of antibiotics.6-脒基青霉烷酸——一类新型抗生素。
Nat New Biol. 1972 Apr 5;236(66):135-7. doi: 10.1038/newbio236135a0.
Zotero 插件